Prenatal Diagnosis Using Chromosomal Microarray Analysis in High-Risk Pregnancies

Ching Hua Hsiao*, Jia Shing Chen, Yu Ming Shiao, Yann Jang Chen, Ching Hsuan Chen, Woei Chyn Chu, Yi Cheng Wu

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


Background: To assess the value of chromosomal microarray analysis (CMA) during the prenatal diagnosis of high-risk pregnancies. Methods: Between January 2016 and November 2021, we included 178 chorionic villi and 859 amniocentesis samples from consecutive cases at a multiple tertiary hospital. Each of these high-risk singleton pregnancies had at least one of the following indications: (1) advanced maternal age (AMA; ≥35 years; 546, 52.7%); (2) fetal structural abnormality on ultrasound (197, 19.0%); (3) high-risk first-or second-trimester Down syndrome screen (189, 18.2%), including increased nuchal translucency (≥3.5 mm; 90, 8.7%); or (4) previous pregnancy, child, or family history (105, 10.1%) affected by chromosomal abnormality or genetic disorder. Both G-banding karyotype analysis and CMA were performed. DNA was extracted directly and examined with oligonucleotide array-based comparative genomic hybridization. Results: Aneuploidies were detected by both G-banding karyotyping and CMA in 42/1037 (4.05%) cases. Among the 979 cases with normal karyotypes, 110 (10.6%) cases had copy number variants (CNVs) in CMA, including 30 (2.9%) cases with reported pathogenic and likely pathogenic CNVs ≥ 400 kb, 37 (3.6%) with nonreported VOUS, benign, or likely benign CNVs ≥ 400 kb, and 43 (4.1%) with nonreported CNVs < 400 kb. Of the 58 (5.6%) cases with aneuploidy rearrangements, 42 (4.1%) were diagnosed by both G-banding karyotyping and CMA; four inversions, six balanced translocations, and six low mosaic rates were not detected with CMA. Conclusions: CMA is an effective first step for the prenatal diagnosis of high-risk pregnancies with fetal structural anomalies found in ultrasonography or upon positive findings.

Original languageEnglish
Article number3624
JournalJournal of Clinical Medicine
Issue number13
StatePublished - 1 Jul 2022


  • amniotic fluid (AF)
  • chorionic villus sampling (CVS)
  • chromosomal microarray analysis (CMA)
  • copy number variants (CNVs)
  • variants of unknown significance (VOUS)


Dive into the research topics of 'Prenatal Diagnosis Using Chromosomal Microarray Analysis in High-Risk Pregnancies'. Together they form a unique fingerprint.

Cite this